Trending Topic

3D rendered Medical Illustration of Male Anatomy - Rectal Cancer.
14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Gabriel Valagni, Nkafu Bechem Ndemazie, Tiago Biachi de Castria

Trifluridine/tipiracil (FTD/TPI) is a novel oral formulation of two drugs with promising results in the treatment of metastatic colorectal cancer (mCRC).1 Trifluridine is a thymidine-based nucleoside analogue that, after intracellular phosphorylation, gets incorporated into DNA, causing DNA dysfunction.2 It was first identified by Callahan et al. in 1996 as an active impurity in the herbicide trifluralin, which […]

Lena Sharp, ESMO 2018 – The European Oncology Nursing Society

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 2nd 2018

Almost 60% of European countries do not recognise cancer nursing as a defined specialty, and therefore do not provide targeted educational programmes. This has resulted in vast differences in the education levels and roles of cancer nurses across European countries. The CARE strategy, developed by the European Oncology Nursing Society (EONS), is made up of 31 national cancer nursing societies and aims to address these issues. They run educational events and conferences, and provide online learning resources, among other valuable services. Lena Sharp, President of EONS, gives us an insight into the CARE strategy and the difficulties prevalent in cancer nursing, and how EONS are working with ESMO to create change in this area.

Questions:
1. Could you tell us a little about the aims of the European Oncology Nursing Society (EONS)? (0:11)
2. What are the goals of the CARE strategy? (0:39)
3. What resources does EONS provide to cancer nurses? (1:00)
4. What are the major challenges to EONS in the coming years? (1:35)
5. What are the key messages from ESMO that will help the aims of EONS? (2:01)

Speaker disclosures: Lena Sharp has nothing to disclose in relation to this interview.

Filmed at the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany, 19–23 October 2018

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup